CL184
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CL184, covering 2011-09-21 to 2013-04-10. Get the full timeline:
Most recent: Clinical Trial Update: Rabies Virus Neutralizing Activity and Safety of CL184, a Monoclonal Antibody Cocktail, in Simulated Rabies Post-Exposure Prophylaxis in Healthy Adults [Phase 2]